Merck (MRK) EV to CFO (2009 - 2026)
Merck's (MRK) quarterly EV to CFO came in at 57.72 in Q2 2026, little changed year-over-year from 57.45 in Q2 2025, and down 22.41% quarter-over-quarter from 74.39 in Q1 2026.
Analysis
Merck (MRK) EV to CFO (2009 - 2026) Analysis & Trends
Merck (MRK) has reported EV to CFO for 18 consecutive years, with 57.72 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to CFO changed 0.47% year-over-year to 57.72 in Q2 2026; TTM through Jun 2026 was 15.52, a 52.08% increase from a year earlier, with the FY2025 full-year figure at 14.92, up 34.76% from the prior year.
- EV to CFO was 57.72 for Q2 2026 at Merck, down from 74.39 in the prior quarter.
- Over five years, EV to CFO peaked at 1093.78 in Q4 2023 and troughed at 24.31 in Q3 2025.
- A 5-year average of 124.06 and a median of 59.17 in 2022 frame the typical range for EV to CFO.
- Across the five-year window, EV to CFO jumped 1704.42% in 2023 and plunged 93.7% in 2024, its largest moves.
- Over 5 years, EV to CFO stood at 60.62 in 2022, then jumped by 1704.42% to 1093.78 in 2023, then sank by 93.7% to 68.89 in 2024, then gained by 24.86% to 86.01 in 2025, then plunged by 32.9% to 57.72 in 2026.
- The last three EV to CFO figures came in at 57.72 (Q2 2026), 74.39 (Q1 2026), and 86.01 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.72 |
| Mar 31, 2026 | 74.39 |
| Dec 31, 2025 | 86.01 |
| Sep 30, 2025 | 24.31 |
| Jun 30, 2025 | 57.45 |
| Mar 31, 2025 | 86.49 |
| Dec 31, 2024 | 68.89 |
| Sep 30, 2024 | 29.35 |
| Jun 30, 2024 | 53.67 |
| Mar 31, 2024 | 106.36 |
| Dec 31, 2023 | 1,093.78 |
| Sep 30, 2023 | 32.68 |
| Jun 30, 2023 | 77.34 |
| Mar 31, 2023 | 193.91 |
| Dec 31, 2022 | 60.62 |
| Sep 30, 2022 | 36.98 |
| Jun 30, 2022 | 51.35 |
| Mar 31, 2022 | 41.72 |
| Dec 31, 2021 | 36.45 |
| Sep 30, 2021 | 37.48 |